These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 608165)

  • 41. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A; Fumagalli S; Marini M; Di Serio C; Tarantini F; Boncinelli L; Baldereschi G; Valoti P; La Cava G; Olianti C; Masotti G; Marchionni N
    Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopamine--clinical uses of an endogenous catecholamine.
    Goldberg LI
    N Engl J Med; 1974 Oct; 291(14):707-10. PubMed ID: 4604342
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute hemodynamic effects of dopamine in patients with shock.
    Loeb HS; Winslow EB; Rahimtoola SH; Rosen KM; Gunnar RM
    Circulation; 1971 Aug; 44(2):163-73. PubMed ID: 4935052
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock.
    Udesen NLJ; Helgestad OKL; Banke ABS; Frederiksen PH; Josiassen J; Jensen LO; Schmidt H; Edelman ER; Chang BY; Ravn HB; Møller JE
    Crit Care; 2020 Mar; 24(1):95. PubMed ID: 32188462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic effects of dopamine in patients with resistant congestive heart failure.
    Durairaj SK; Haywood LJ
    Clin Pharmacol Ther; 1978 Aug; 24(2):175-85. PubMed ID: 354838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined nitroprusside-dopamine therapy in severe chronic congestive heart failure. Dose-related hemodynamic advantages over single drug infusions.
    Stemple DR; Kleiman JH; Harrison DC
    Am J Cardiol; 1978 Aug; 42(2):267-75. PubMed ID: 685839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
    Dawson JR; Thompson DS; Signy M; Juul SM; Turnbull P; Jenkins BS; Webb-Peploe MM
    Br Heart J; 1985 Sep; 54(3):313-20. PubMed ID: 4041300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The hemodynamic effects of dopamine following cardiopulmonary bypass.
    Merin G; Bitran D; Uretzky G; Superstine E; Cotev S; Borman JB
    Ann Thorac Surg; 1977 Apr; 23(4):361-3. PubMed ID: 849049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute haemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failure.
    Wang RY; Chow JS; Chan KH; Pan HY; Wong RP
    Eur Heart J; 1984 Sep; 5(9):745-51. PubMed ID: 6499862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
    Reiz S; Friedman A
    Acta Anaesthesiol Scand; 1980; 24(1):5-10. PubMed ID: 7376804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hemodynamic effects of intravenous tocainide in patients with heart disease.
    Winkle RA; Anderson JL; Peters F; Meffin PJ; Fowles RE; Harrison DC
    Circulation; 1978 Apr; 57(4):787-92. PubMed ID: 630689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodynamic effects of chlorpromazine in patients with acute myocardial infarction and pump failure.
    Elkayam U; Rotmensch HH; Terdiman R; Geller E; Laniado S
    Chest; 1977 Nov; 72(5):623-7. PubMed ID: 913142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic effects of dopamine and dopamine combined with nitroglycerin in patients subjected to coronary bypass surgery.
    Hess W; Klein W; Mueller-Busch C; Tarnow J
    Br J Anaesth; 1979 Nov; 51(11):1063-9. PubMed ID: 117821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of short-term norepinephrine up-titration on hemodynamics in cardiogenic shock.
    Rokyta R; Tesařová J; Pechman V; Gajdos P; Kroužecký A
    Physiol Res; 2010; 59(3):373-378. PubMed ID: 19681659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiologic basis for the therapeutic use of catecholamines.
    Rosenblum R
    Am Heart J; 1974 Apr; 87(4):527-30. PubMed ID: 4817111
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock.
    Malik FS; Mehra MR; Uber PA; Park MH; Scott RL; Van Meter CH
    J Card Fail; 1999 Mar; 5(1):31-7. PubMed ID: 10194658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure.
    Rousseau MF; Raigoso J; van Eyll C; Van Mechelen H; Musso NR; Lotti G; Pouleur H
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):155-62. PubMed ID: 1376782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of digitalis on hemodynamics in acute myocardial infarct. II. Myocardial infarct associated with acute severe insufficiency of the left heart and cardiogenic shock].
    Schüren KP; Ramdohr B; Dissmann W; Buschmann HJ; Schröder R
    Klin Wochenschr; 1970 May; 48(10):591-7. PubMed ID: 5517327
    [No Abstract]   [Full Text] [Related]  

  • 60. Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
    De Marco T; Kwasman M; Lau D; Chatterjee K
    Am J Cardiol; 1988 Aug; 62(5):57C-62C. PubMed ID: 3407596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.